510(k) Report

510(k) · Cleared

Cleared

NovoSorb Matrix

K221686510(k) SpecialCleared Sep 15, 202297-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Polynovo Biomaterials Pty, Ltd. · QSZ Absorbable Synthetic Wound Dressing

Cleared on Sep 15, 2022 after a 97-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 2 later devices descend from it.

Decided
Sep 15, 2022
Review
97 days
Class
Class U
Product code
QSZ
Recalls
None
Predicates
0

2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2025: 2 descendants cleared2020202220242026
  1. This deviceK221686 NovoSorb MatrixPolynovo Biomaterials Pty, Ltd. · 2022
  2. Descendant · cites it directly · 1 of its ownK242149 NovoSorb® MTXPolynovo Biomaterials Pty, Ltd. · 2025
  3. Descendant · 2 generations on · 0 of its ownK251567 NovoSorb BTMPolynovo Biomaterials Pty, Ltd. · 2025

Most influential descendants

Showing 2 of 2 · See all
  • K242149NovoSorb® MTXPolynovo Biomaterials Pty, Ltd. · 2025 · cites it directly1descendant
  • K251567NovoSorb BTMPolynovo Biomaterials Pty, Ltd. · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K221686NovoSorb MatrixPolynovo Biomaterials Pty, Ltd.2022—
+1K242149NovoSorb® MTXPolynovo Biomaterials Pty, Ltd.2025—
+2K251567NovoSorb BTMPolynovo Biomaterials Pty, Ltd.2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202520
FIG. 1 — Lineage of K221686, 2022–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QSZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QSZ device

  1. #1 K254256 LUOFUCON® Wound Matrixscore 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K242149NovoSorb® MTXPolynovo Biomaterials Pty, Ltd.20251

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K242149 (Polynovo Biomaterials Pty, Ltd., 2025) has gone furthest, with 1 descendant of its own.

How does its category compare?

All QSZ devices

QSZ Absorbable Synthetic Wound Dressing: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · QSZ

4so far in 2026, the most since 2007

2007: 12009: 12014: 12015: 12016: 12017: 32018: 12020: 12022: 22023: 22024: 12025: 22026 (partial year): 4
2007high 4 (2026) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QSZ

85in 2017

2017: 85 days median2026 (partial year): 159 days median
2007high 159 (2026) · low 85 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QSZ

No recall names QSZ since 2007.

Adverse event reports per year · QSZ

38in 2025

2023: 152024: 152025: 38
2007high 38 (2025) · low 0 (2007)2025

MAUDE reports naming product code QSZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20091—00
20100—00
20110—00
20120—00
20130—00
20141—00
20151—00
20161—00
201738500
20181—00
20190—00
20201—00
20210—00
20222—00
20232—015
20241—015
20252—038
202641590—

What is it indicated for?

NovoSorb® Matrix is indicated for use in the management of wounds including: partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic and vascular ulcers, surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, partial thickness burns, and skin tears) and draining wounds.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K221686: NovoSorb Matrix.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K221686

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026